Expression of CD56 on a variety of malignant and pre-malignant cells has been reported in patients, including those with precursor T-cell lymphoblastic leukemia/lymphoma (T-ALL/LBL) cells [65-68]. This evidence concerns the gene NCAM1 and lymphoma.